Is There Sufficient Evidence to Support HCT in Older Adults with ALL?
Is There Sufficient Evidence to Support HCT in Older Adults with ALL?
Track: BMT Tandem "Scientific" Meeting
Wednesday, February 26, 2014, 8:30 AM-10:00 AM
Texas B+D (Gaylord Texan)
Disclosures:
A. Fielding,
Amgen, Consultant: Advisory Board
Sigma Tau, Consultant: Advisory Board and Research Funding
Pfizer, Consultant: Advisory Board
Sigma Tau, Consultant: Advisory Board and Research Funding
Pfizer, Consultant: Advisory Board